Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

32,500

Employees32,500

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

32,500

Employees32,500

BMY Key Statistics

Market cap

113.15B

Market cap113.15B

Price-Earnings ratio

15.44

Price-Earnings ratio15.44

Dividend yield

4.55%

Dividend yield4.55%

Average volume

13.92M

Average volume13.92M

High today

$56.18

High today$56.18

Low today

$54.81

Low today$54.81

Open price

$55.47

Open price$55.47

Volume

11.16M

Volume11.16M

52 Week high

$62.89

52 Week high$62.89

52 Week low

$42.52

52 Week low$42.52

Stock Snapshot

With a market cap of 113.15B, Bristol-Myers Squibb(BMY) trades at $55.44. The stock has a price-to-earnings ratio of 15.44 and currently yields dividends of 4.55%.

As of 2026-06-25, Bristol-Myers Squibb(BMY) stock has fluctuated between $54.81 and $56.18. The current price stands at $55.44, placing the stock +1.1% above today's low and -1.3% off the high.

The Bristol-Myers Squibb(BMY)'s current trading volume is 11.16M, compared to an average daily volume of 13.92M.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $42.52 at its lowest and $62.89 at its peak.

BMY News

Simply Wall St 14h

What Bristol-Myers Squibb's Phase 3 Izalontamab Results Mean For Shareholders

Earlier in June, Bristol Myers Squibb and SystImmune reported interim Phase 3 results showing izalontamab brengitecan improved overall and progression-free surv...

Nasdaq 2d

Bristol Myers Squibb Ascends While Market Falls: Some Facts to Note

Bristol Myers Squibb (BMY) closed the most recent trading day at $60.18, moving +0.6% from the previous trading session. The stock's performance was ahead of th...

Simply Wall St 2d

Bristol Myers Squibb Stock Could Be 13% Undervalued As Pipeline Plans Take Shape

Bristol-Myers Squibb (BMY) has been in focus after its board declared a quarterly dividend of $0.63 per share, payable on August 3, 2026, to shareholders of rec...

Analyst ratings

61%

of 31 ratings

Buy

35.5%

Hold

61.3%

Sell

3.2%

More BMY News

Benzinga 6d

The Nasdaq 100 Has Tripled Since 2020, But These 10 Mega-Caps Are Still Underwater

In mid-February 2020 global equities were sitting at record highs, lifted by a decade-long bull market, rock-bottom interest rates and a U.S. economy near full...

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.